Stramsen Biotech Thanks the FDA for Their Review and Positive Feedback on Pre IND Application for SBX-1977 Wound Care Medicine

The company is seeking law firms and investment banks for potential capital market partnerships; two Experienced Co-CFOs have joined Stramsen. HOUSTON, June 2, 2026 /PRNewswire/ -- Stramsen Biotech, announced today that it has received written feedback from the U.S. Food and Drug...